
Late Conversion From Calcineurin Inhibitors to Belatacept in Kidney-Transplant Recipients Has a Significant Beneficial Impact on Glycemic Parameters
Author(s) -
Florian Terrec,
Thomas Jouvé,
Hamza Naciri-Bennani,
PierreYves Benhamou,
Paolo Malvezzi,
Bénédicte Janbon,
Diane Giovannini,
Lionel Rostaing,
Johan Noble
Publication year - 2019
Publication title -
transplantation direct
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 0.648
H-Index - 9
ISSN - 2373-8731
DOI - 10.1097/txd.0000000000000964
Subject(s) - medicine , calcineurin , glycemic , belatacept , diabetes mellitus , type 2 diabetes , immunosuppression , insulin , urology , transplantation , renal function , clinical endpoint , kidney transplantation , endocrinology , randomized controlled trial , kidney transplant